Literature DB >> 6997964

Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts.

L R Peterson, D N Gerding.   

Abstract

Critical evaluation of existing data on binding of antibiotics to serum proteins and on pharmacokinetics provides several useful principles for administration of antibiotics. With the exception of the aminoglycosides, antibiotics distribute with total body water, and the concept of a variable apparent volume of distribution leads to incorrect assumptions about restricted extravascular penetration. Antibiotics with a high degree of binding to serum proteins are not necessarily inferior; raising a given drug's binding to serum proteins from 0 to 90% reduces the concentration of free drug in serum and tissue by only one-half. The concentration of an antibiotic in extravascular fluid is essentially constant despite the marked variability of serum levels seen during intermittent administration of the drug. An important factor in determining a successful therapeutic response is maintenance of the level of free antibiotic in extravascular fluid above the minimal inhibitory concentration for the infecting organism. Finally, the extravascular distribution, tissue binding, and free-drug concentration of an antibiotic can be accurately predicted from serum kinetics and serum protein binding.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997964     DOI: 10.1093/clinids/2.3.340

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  35 in total

1.  Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens.

Authors:  G H Ross; L B Hovde; K H Ibrahim; Y H Ibrahim; J C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

2.  Highly reproducible bactericidal activity test results by using a modified National Committee for Clinical Laboratory Standards broth macrodilution technique.

Authors:  D M Hacek; D C Dressel; L R Peterson
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 3.  Clinical role of protein binding of quinolones.

Authors:  Eugénie Bergogne-Bérézin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.

Authors:  Toshimi Kimura; Keisuke Sunakawa; Nobuo Matsuura; Hiroaki Kubo; Shigehiko Shimada; Kazuo Yago
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

5.  Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.

Authors:  S K Nath; G A Foster; L A Mandell; C Rotstein
Journal:  Can J Infect Dis       Date:  1995-01

Review 6.  Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 7.  Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.

Authors:  Jürgen Beer; Claudia Christina Wagner; Markus Zeitlinger
Journal:  AAPS J       Date:  2009-01-01       Impact factor: 4.009

8.  Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model.

Authors:  L R Peterson; L L Van Etta; C E Fasching; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

9.  Furosemide disposition in patients on CAPD.

Authors:  U Martin; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

10.  In vitro protein binding of cefonicid and cefuroxime in adult and neonatal sera.

Authors:  J M Benson; F D Boudinot; A T Pennell; F E Cunningham; J T DiPiro
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.